Keyphrases
Head-and-neck
100%
Squamous Cell Carcinoma of Head
100%
Enhancement Mechanism
100%
Tumor-infiltrating Lymphocytes
100%
Prostaglandins
100%
Prostaglandin Inhibitors
100%
Prostaglandin E2
77%
Indomethacin
66%
Clinical Response
44%
Malignancy
33%
Tumor
33%
Host Immune Response
33%
Lymphocytes
33%
Head-and-neck Cancer
22%
Immune Response
22%
Keto
22%
Lymphocyte Subsets
22%
Liming Effect
22%
Tumor-associated
22%
Tissue Sampling
11%
Immunomodulation
11%
Tumor Cells
11%
Cell Systems
11%
Treatment Strategy
11%
Metabolism
11%
Local Level
11%
Interleukin-2
11%
Local-regional
11%
Cell Manufacturing
11%
CD56
11%
Squamous Cell Carcinoma (SqCC)
11%
Immunomodulatory Therapy
11%
Immunohistochemical Analysis
11%
Inhibitory Effect
11%
Effector Cells
11%
Interleukin-1β
11%
In Vitro Assay
11%
Two-cell
11%
Supernatant
11%
Indirect Immunofluorescence
11%
Tumor Tissue
11%
Human Tumors
11%
Tongue
11%
CD18
11%
Significant Level
11%
Prostaglandin Synthesis
11%
Prostaglandin Metabolism
11%
Tonsillar
11%
Serial Biopsy
11%
Tumor Regression
11%
New Therapeutic Approaches
11%
Human Squamous Cell Carcinoma
11%
Local Immunosuppression
11%
Neck Cell
11%
Immunocyte
11%
Epiglottis
11%
Mononuclear Leukocytes
11%
CD8 Lymphocytes
11%
CD4 Lymphocytes
11%
Tumor Surveillance
11%
Squamous Carcinoma Cells
11%
Retromolar Trigone
11%
Fold Increase
11%
Tumor-infiltrating Leukocytes
11%
Prostaglandin Metabolite
11%
Systemic Immunosuppression
11%
Medicine and Dentistry
Neck
100%
Squamous Cell Carcinoma
100%
Tumor Infiltrating Lymphocyte
100%
Prostaglandin Synthase Inhibitor
100%
Neoplasm
88%
Prostaglandin
77%
Prostaglandin E2
77%
Indometacin
66%
Immune Response
55%
Prostaglandin Synthesis
44%
Lymphocyte
44%
Cancer
33%
Cell Line
33%
Head and Neck Cancer
22%
Immunity
22%
Lymphocyte Subpopulation
22%
Prostaglandin F1 Alpha
22%
In Vitro
11%
Tumor Cell
11%
Immunosuppressive Treatment
11%
Leukocyte
11%
Immunomodulation
11%
Tongue
11%
Interleukin 1
11%
Prostaglandin Metabolism
11%
Biopsy Technique
11%
Effector Cell
11%
Squamous Cell Carcinoma Cell
11%
CD18 Antigen
11%
CD2 Antigen
11%
Epiglottis
11%
Tumor Regression
11%
Prostaglandin Metabolite
11%
CD8 Antigen
11%
Immunofluorescence
11%
Immunosuppressive Drug
11%
Interleukin 2
11%
Peripheral Blood Mononuclear Cell
11%
Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
Prostaglandin Synthase Inhibitor
100%
Neoplasm
100%
Prostaglandin
100%
Prostaglandin E2
53%
Indometacin
46%
Prostaglandin F1 Alpha
15%
Head and Neck Cancer
15%
Immunomodulation
7%
CD8 Antigen
7%
Immunosuppressive Agent
7%
Interleukin 1
7%
Tumor Regression
7%
CD18 Antigen
7%
Interleukin 2
7%
CD2 Antigen
7%